CompareEko HealthvsAnumana

Eko Health is a company combining digital stethoscopes with AI that helps detect heart and lung conditions during exams. The product is positioned around cardiac imaging support and risk stratification rather than autonomous cardiology, and cardiologist review of every interpretation remains essential for treatment and reporting decisions. Buyers should confirm regulatory clearance scope, imaging modality fit, reporting integration, and clinical validation evidence before rolling out across active cardiology service lines today.

Eko Health works best for primary care and cardiology clinicians, and its edge is AI stethoscope for heart and lung signals. The honest trade-off here: positive findings need clinician confirmation. Pricing is sales-led and scoped per buyer rather than posted publicly. Run a small pilot to confirm fit before committing to a wider rollout.

Anumana is an AI company developing ECG algorithms that flag cardiac conditions to support earlier detection by clinicians. The product is positioned around cardiac imaging support and risk stratification rather than autonomous cardiology, and cardiologist review of every interpretation remains essential for treatment and reporting decisions. Buyers should confirm regulatory clearance scope, imaging modality fit, reporting integration, and clinical validation evidence before rolling out across active cardiology service lines today.

Anumana works best for cardiology and health system programs, and its edge is ECG-AI for earlier cardiac detection. The honest trade-off here: clearance scope varies by algorithm. Pricing is sales-led and scoped per buyer rather than posted publicly. Run a small pilot to confirm fit before committing to a wider rollout.